Brian Elsbernd Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

CPRX Quotes by TradingView

Brian Elsbernd is Chief Compliance/Legal Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 242,501 shares of CPRX, which is worth approximately $5.62 Million. The most recent transaction as insider was on Feb 15, 2024, when has been sold 9,667 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 243K
10.53% 3M change
33.79% 12M change
Total Value Held $5.62 Million

Brian Elsbernd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
9,667 Added 5.99%
151,786 Common Stock, par valu...
Dec 27 2023
SELL
Payment of exercise price or tax liability
-
2,623 Reduced 1.81%
142,119 Common Stock, par valu...
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
6,666 Added 4.4%
144,742 Common Stock, par valu...
Mar 20 2023
SELL
Open market or private sale
$803,500 $16.07 p/Share
50,000 Reduced 26.58%
138,076 Common Stock, par valu...
Mar 20 2023
BUY
Exercise of conversion of derivative security
$56,499 $1.13 p/Share
50,000 Added 21.0%
188,076 Common Stock, par valu...
Feb 15 2023
SELL
Payment of exercise price or tax liability
-
2,353 Reduced 1.68%
138,076 Common Stock, par valu...
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
9,666 Added 6.44%
140,429 Common Stock, par valu...
Dec 06 2022
BUY
Exercise of conversion of derivative security
-
14,667 Added 10.09%
130,763 Common Stock, par valu...
Nov 14 2022
BUY
Exercise of conversion of derivative security
$138,600 $1.32 p/Share
105,000 Added 47.49%
116,096 Common Stock, par valu...
Nov 11 2022
SELL
Open market or private sale
$238,029 $16.23 p/Share
14,666 Reduced 56.93%
11,096 Common Stock, par valu...
Dec 03 2021
SELL
Payment of exercise price or tax liability
-
3,571 Reduced 12.17%
25,762 Common Stock, par valu...
Dec 03 2021
BUY
Exercise of conversion of derivative security
-
14,667 Added 33.33%
29,333 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
14,666 Added 50.0%
14,666 Common Stock, par valu...
BE

Brian Elsbernd

Chief Compliance/Legal Officer
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CPRX